A Clinical Compass for Selecting and Sequencing HER2-Targeting Therapies in HER2-Positive Metastatic Breast Cancer: An Update on the Latest Evidence, Guidelines, and Expert Insights

Provider:PVI, PeerView Institute for Medical Education
Activity Link: https://www.peerview.com/MVX
Start Date: 2024-03-05 06:00:00
End Date: 2024-03-05 06:00:00
Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABIM - 1.0 Point; Credit Type(s): Patient Safety (ABIM)
Commercial Support: Source: AstraZeneca (Any division) - Amount: 59907.0 - Is Kind Support: False Source: Daiichi Sankyo, Inc. - Amount: 27557.0 - Is Kind Support: False
Activity Type: Enduring Material
CME Finder Type: Online Learning
Fee to Participate: No, it's free
Measured Outcome: Learner Knowledge, Learner/Team Competence
Provider Ship: Directly Provided
Registration: Open to all
Specialty: Medical Oncology

Contact us